U.S. Markets open in 1 hr, 37 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,058.64 | 150.25 | 1.52% |
| NASDAQ | 2,150.87 | 24.82 | 1.17% |
| S&P 500 | 1,070.52 | 13.78 | 1.30% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 56.72 11:28 AM EST | |
|---|---|---|
| Day High | 57.59 12:20 PM EST |
|
| Range | 0.87 |
| Volume | 1,000 | |
|---|---|---|
| 30-Day Avg Vol | 5.41 M |
|
| Difference | -99.98% |
| Market Cap | 52.07 B | |
|---|---|---|
| Mkt Cap Chg | 164.16 M |
| Shares Out | 912.00 M | |
|---|---|---|
| % Shrs Traded | 0.00% | |
| 1yr EPS Est | 4.236 |
| 52-Wk Low | 41.70 | |
|---|---|---|
| 52-Wk High | 59.62 |
|
| Range | 17.92 |
| Prev Close | 56.92 2/8/10 | |
|---|---|---|
| Today's Open | 57.35 | |
| Change | 0.76% |
| Dividend (TTM) | 0.57985 | |
|---|---|---|
| Div Yield (TTM) | — | |
| Ex-Div Date | 11/06/2009 | |
| Div Date | 12/04/2009 |
|
| Short Interest | 10.98 M |
| Revenue (LFY) | 11.08 B | |
|---|---|---|
| Earnings (LFY) | 635.00 M | |
| Earnings (MRQ) | 674.72 M | |
| Next Earn Est | 0.946 | |
| Next Earnings | 02/16/2010 |
|
| EPS (TTM) | 1.1302 | |
| 1yr EPS Growth | 32.79% |
| P/E Ratio (TTM) | 58.27 | |
|---|---|---|
| P/E Ratio (Fwd) | 13.00 | |
| PEG Ratio | 0.85 | |
| Return on Equity | 4.38 | |
| Beta | 0.18 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
The backbone of Teva Pharmaceutical Industries is its world-leading generic pharmaceuticals business. Through subsidiary Teva Pharmaceuticals USA, the company makes generic versions of hundreds of brand-name ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.946 2/16/10 | — — |
—
—
|
| Last Quarter | 0.879 9/30/09 | 0.89 9/30/09 |
0.011
Beat
|
| 2 Quarters Ago | 0.804 6/30/09 | 0.83 6/30/09 |
0.026
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 3.69 B | 11.08 B |
| Gross Profit | 2.00 B | 5.97 B |
| Operating Income | 883.69 M | 2.67 B |
| Net Income | 674.72 M | 635.00 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts